Roche Holding AG SG&A Expenses 2012-2025 | RHHBY

Roche Holding AG sg&a expenses for the twelve months ending December 31, 2025 were $0M, a 0% increase year-over-year.

  • Roche Holding AG annual sg&a expenses for 2025 were $18.299B, a 8.15% increase from 2024.
  • Roche Holding AG annual sg&a expenses for 2024 were $16.92B, a 2.08% increase from 2023.
  • Roche Holding AG annual sg&a expenses for 2023 were $16.576B, a 26.24% increase from 2022.

Roche Holding AG SG&A Expenses 2012-2025 | RHHBY

  • Roche Holding AG annual sg&a expenses for 2025 were $18.299B, a 8.15% increase from 2024.
  • Roche Holding AG annual sg&a expenses for 2024 were $16.92B, a 2.08% increase from 2023.
  • Roche Holding AG annual sg&a expenses for 2023 were $16.576B, a 26.24% increase from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B